MRCP PACES Consultation: Mastering Inflammatory Bowel Disease Patient Discussions

Why IBD Is a PACES Favourite

Inflammatory Bowel Disease (IBD) — encompassing Crohn's disease and Ulcerative Colitis (UC) — is one of the highest-yield gastroenterology topics in MRCP PACES Stations 2 and 5. Examiners love IBD because it demands a sophisticated blend of clinical knowledge, communication skill, and holistic patient management — all assessed within a tight 10-minute window.

Whether you encounter a young patient with new-onset bloody diarrhoea in Station 2 or a complex Crohn's patient with perianal disease in Station 5, your ability to navigate the consultation with senior-level confidence is what earns you a clear pass.

Understanding What the Examiner Wants

Before diving into clinical content, understand the PACES consultation blueprint:

| Domain | What's Assessed |
||
| Clinical Assessment | Focused history, relevant examination, appropriate differentials |
| Investigations | Correct choice and interpretation of tests |
| Management Plan | Evidence-based, patient-centred, holistic |
| Communication | Clarity, empathy, appropriate jargon-free explanation |
| Managing Complexity | Addressing concerns, shared decision-making |

In IBD scenarios, you must demonstrate not just knowledge of guidelines (BSG, ECCO, NICE) but the maturity to apply them to an individual patient's circumstances.

High-Yield IBD Presentations in PACES

Scenario Type 1: Acute Severe Ulcerative Colitis (Station 2)

Typical Vignette: A 28-year-old presents with 8-10 bloody stools per day, fever, tachycardia, and CRP of 85.

Critical History Elements to Elicit:

• Stool frequency (nocturnal symptoms indicate severity)

• Presence of blood and mucus

• Constitutional symptoms: fever, weight loss, fatigue

• Extraintestinal manifestations: mouth ulcers, joint pain, eye symptoms, skin rashes (erythema nodosum, pyoderma gangrenosum)

• Medication history: NSAIDs (can exacerbate), recent antibiotics (C. difficile risk), cessation of maintenance therapy

• Travel history and sexual history (exclude infective causes)

• Family history of IBD or colorectal cancer

• Psychosocial impact: occupation, relationships, mood

Examiner Pearl: Always assess for corticosteroid contraindications — ask about psychiatric history, diabetes, active infection, and osteoporosis risk before committing to steroids.

Scenario Type 2: Crohn's Disease with Perianal Disease (Station 5)

Typical Vignette: A 35-year-old with known Crohn's disease presents with perianal pain, discharge, and urinary symptoms.

Critical Discussion Points:

• Distinguish between simple and complex perianal fistulae

• Need for examination under anaesthesia (EUA) and pelvic MRI

• Role of anti-TNF therapy (infliximab/adalimumab) with or without immunomodulators

• Surgical options: seton placement, fistulotomy (simple only), advancement flap

• Importance of multidisciplinary team approach involving gastroenterology, colorectal surgery, and stoma nurses

Essential Investigation Framework

When discussing investigations, present them in a logical tiered approach:

Tier 1: Immediate / Bedside

• Full blood count (anaemia, leucocytosis)

• CRP and ESR (disease activity markers — CRP is more responsive)

• U&E, LFTs, albumin (low albumin indicates severe disease)

• Stool culture, C. difficile toxin, and calprotectin (exclude infection; calprotectin >250 µg/g suggests active IBD)

• Abdominal X-ray (toxic megacolon assessment in acute severe UC)

Tier 2: Endoscopic and Histological

• Flexible sigmoidoscopy or colonoscopy with biopsies (gold standard for diagnosis)

• Mayo Score for UC severity (endoscopic subscore is critical)

• Histology: crypt abscesses and continuous mucosal involvement favour UC; skip lesions and granulomas favour Crohn's

Tier 3: Advanced Imaging

• MRI enterography (small bowel Crohn's — strictures, fistulae)

• Intestinal ultrasound (increasingly used for monitoring — know this as a recent advance)

• Capsule endoscopy (small bowel visualisation when MRI is equivocal)

High-Yield Fact for PACES: Always mention faecal calprotectin as a non-invasive marker. It's now a first-line investigation in NICE guidelines for distinguishing IBD from IBS in adults.

Structuring Your Management Discussion

The key to passing IBD consultations is presenting a structured, escalating management plan that demonstrates awareness of:

1. Induction of Remission

2. Maintenance of Remission

• UC: 5-ASA maintenance; azathioprine/6-MP for steroid-dependency; colectomy is curative

• Crohn's: Azathioprine/6-MP or methotrexate; anti-TNF for maintenance; surgery is not curative but may be necessary for strictures/fistulae

3. The Rescue Therapy Conversation (Acute Severe UC)

This is a classic Station 5 discussion point. If a patient fails IV steroids by Day 3 (based on the Oxford Criteria: >8 stools/day OR 3-8 stools/day with CRP >45), you must discuss:

• Infliximab 5mg/kg (single dose) — 7-day response window

• Cyclosporin 2mg/kg/day IV (4mg/kg if oral) — equally effective

• Colectomy — the definitive but life-changing option

Communication Tip: Frame colectomy not as a failure but as a potentially curative option. Discuss stomas and J-pouch surgery sensitively. Mention the involvement of stoma care nurses and IBD specialist nurses.

Critical Safety Points Examiners Test

1. Pre-Biologic Screening

Before starting anti-TNF therapy, always mention:

• TB screening (interferon-gamma release assay + chest X-ray)

• Hepatitis B and C screening

• HIV testing

• Cardiac failure assessment (anti-TNF can worsen NYHA Class III/IV)

• Demyelinating disease exclusion

• Vaccination status (live vaccines contraindicated once on biologic)

2. Cancer Surveillance

• Colorectal cancer surveillance colonoscopy: starting 8-10 years after diagnosis (or from age 50 for UC patients with pancolitis), then every 1-5 years depending on risk stratification

• Discuss dysplasia and the implications for colectomy

3. Venous Thromboembolism Prophylaxis

• IBD flares carry a significantly increased VTE risk — mention prophylactic LMWH for all hospitalised IBD patients (NICE guidance)

4. Bone Health

• Chronic steroid use → DEXA scan and bone protection with calcium/vitamin D ± bisphosphonate

Mastering the Communication Domain

The Sensitive Topics

1. Steroid Side Effects Discussion
Don't just list — contextualise: "I'll prescribe steroids because they work quickly to control the inflammation, but I want to discuss potential side effects so we can manage them together..."

2. Immunosuppression and Fertility/Pregnancy

• Azathioprine is safe in pregnancy (a frequently tested point)

• Methotrexate is absolutely contraindicated

• Anti-TNF: continue through pregnancy if needed; infliximab and adalimumab cross placenta in third trimester — discuss paediatric vaccination timing (no live vaccines for 6 months)

• Surgery and fertility: pelvic surgery in Crohn's may affect fertility; ileal pouch-anal anastomosis in females may reduce fertility by up to 50%

3. Lifestyle and Psychosocial Impact

• Discuss smoking cessation in Crohn's (smoking worsens Crohn's but may be protective in UC — paradox worth mentioning)

• Employment rights under the Equality Act 2010

• Signpost Crohn's & Colitis UK for patient support

• Screen for anxiety and depression — 25% of IBD patients have significant psychological comorbidity

Practice Framework: The 10-Minute IBD Consultation

Use this structure in Station 2 or 5:

Common Candidate Pitfalls to Avoid

1. Jumping to biologics before establishing disease severity and excluding infection

2. Forgetting to mention stool infections before diagnosing a flare

3. Neglecting extraintestinal manifestations — always ask about eyes, joints, and skin

4. Not discussing VTE prophylaxis in hospitalised patients

5. Overlooking mental health and psychosocial impact

6. Being vague about surgical options — know when surgery is indicated and the key procedures

7. Not using the BSG/ECCO guidelines as your evidence base — citing them shows senior-level practice

Key Guidelines to Reference in PACES

• NICE NG129 (Ulcerative Colitis management, 2019)

• NICE CG152 (Crohn's Disease management, 2012, updated 2019)

• BSG Consensus Guidelines on IBD management

• ECCO Guidelines — particularly for perianal Crohn's and biologic use

Final Examiner Tips

1. Speak to the patient, not just the examiner — communication is scored separately

2. Use the patient's own language — mirror their terminology for symptoms

3. Acknowledge uncertainty — saying "I would discuss this with the MDT" is far better than guessing

4. Demonstrate safety consciousness — always mention infection exclusion before treating a flare

5. Be structured — a clear, logical presentation shows clinical maturity

IBD consultations in PACES reward candidates who can integrate clinical reasoning, evidence-based management, and compassionate communication. Practise these scenarios with timed mock consultations, focusing especially on the transition from acute management to long-term care planning — this is where many candidates falter and where confident, well-prepared candidates shine.

Good luck with your PACES preparation. Master these IBD scenarios, and you'll approach the consultation stations with the confidence of a registrar ready for consultant practice.